201286-96-6

Basic information

• Product Name: 3-Methyl-1H-indazole-6-carboxylic acid
• Synonyms: 3-Methyl-1H-indazole-6-carboxylic acid
• CAS NO: 201286-96-6
• Molecular Formula: C9H8N2O2
• Molecular Weight: 176
• EINECS: 604-604-1
• Mol File: 201286-96-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 439.112 °C at 760 mmHg
• Flash Point: 219.368 °C
• Appearance: /
• Density: 1.421
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-Methyl-1H-indazole-6-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methyl-1H-indazole-6-carboxylic acid(201286-96-6)
• EPA Substance Registry System: 3-Methyl-1H-indazole-6-carboxylic acid(201286-96-6)

Safety Data

• Hazardous Substances Data: 201286-96-6(Hazardous Substances Data)

Usage

General Description

3-Methyl-1H-indazole-6-carboxylic acid is a chemical compound with the molecular formula C10H9NO2. It belongs to the class of organic compounds known as indazoles, which are heterocyclic compounds containing an indazole moiety. 3-Methyl-1H-indazole-6-carboxylic acid is a derivative of indazole, with a methyl and carboxylic acid group attached to specific positions on the molecule. It has potential applications in the pharmaceutical industry, particularly in the synthesis of novel drug candidates. 3-Methyl-1H-indazole-6-carboxylic acid may exhibit biological activity and has been studied for its potential pharmacological effects, making it an important compound in medicinal chemistry research.

Upstream product

• 540-80-7 tert.-butylnitrite 
• 5129-23-7 3-Amino-4-ethyl benzoic acid 
• 103440-95-5 4-Ethyl-3-nitrobenzoic acid 
• 7746-29-4 6-methoxy-3-methyl-1H-indazole 
• 201286-99-9 3-methyl-1H-indazol-6-ol 
• 74457-86-6 1-(2-fluoro-4-methoxyphenyl)-1-ethanone 
• 201286-98-8 3-methyl-1-[(trifluoromethyl)sulfonyl]-1H-indazol-6-yl trifluoromethanesulfonate 
• 201286-97-7 methyl 3-methyl-1-[(trifluoromethyl)sulfonyl]-1H-indazole-6-carboxylate 
• 619-64-7 p-ethylbenzoic acid 

Downstream Products

• 219764-07-5 6-carboxy-1-(2-chloro-4-phenylbenzyl)-3-methyl-1H-indazole 
• 219763-47-0 6-carboxy-1-(2,4-dichlorobenzyl)-3-methyl-1H-indazole 
• 219764-09-7 1-(4-bromo-2-chlorobenzyl)-6-carboxy-3-methyl-1H-indazole 
• 201286-95-5 6-(methoxycarbonyl)-3-methyl-1H-indazole 

Relevant articles and documents

SPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS

The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating mammals suffering from the condition of being overweight.

Substituted azabicyclic compounds

This invention is directed to certain physiologically active compounds of formula (I) wherein represents a bicyclic ring system, of about 10 to about 13 ring members, in which the ring is an azaheterocycle, and the ring represents an azaheteroaryl ring, or an optionally halo substituted benzene ring; and N-oxides thereof, and their prodrugs, and pharmaceutically acceptable salts and solvates of the compounds of formula (I) and N-oxides thereof, and their prodrugs. Such compounds inhibit the production or physiological effects of TNF and inhibit cyclic AMP phosphodiesterase. The invention is also directed to pharmaceutical compositions comprising compounds of formula (I), their pharmaceutical use and methods for their preparation.